UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program

Journal of clinical oncology, 1993-10, Vol.11 (10), p.1957-1968

1993

Volltextzugriff (PDF)

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study

Annals of oncology, 1997-05, Vol.8 (5), p.439-444

1997

Volltextzugriff (PDF)

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study

Journal of clinical oncology, 1991-08, Vol.9 (8), p.1438-1445

1991

Volltextzugriff (PDF)

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer

Journal of clinical oncology, 1995-06, Vol.13 (6), p.1436-1442

1995

Volltextzugriff (PDF)

A study of infusional cisplatin and infusional fluorouracil for locally advanced or metastatic non-small-cell lung cancer: a Mid-Atlantic Oncology Program study

Journal of clinical oncology, 1991-12, Vol.9 (12), p.2162-2166

1991

Volltextzugriff (PDF)

Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

JNCI : Journal of the National Cancer Institute, 1993-05, Vol.85 (10), p.801-806

1993

Volltextzugriff (PDF)

Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil

Cancer chemotherapy and pharmacology, 1991-01, Vol.28 (3), p.217-219

1991

Volltextzugriff (PDF)

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

Cancer chemotherapy and pharmacology, 1992, Vol.30 (3), p.199-206

1992

Volltextzugriff (PDF)

A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer : a mid-atlantic oncology program study

American journal of clinical oncology, 1992-02, Vol.15 (1), p.12-17

1992

Volltextzugriff (PDF)

Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer : a MAOP study

American journal of clinical oncology, 1991-10, Vol.14 (5), p.442-445

1991

Volltextzugriff (PDF)

Relationships between various uses of antineoplastic drug-interaction terms

Cancer chemotherapy and pharmacology, 1992-03, Vol.31 (2), p.111-117

1992

Volltextzugriff (PDF)

Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium

Journal of inorganic biochemistry, 1985-09, Vol.25 (1), p.51-55

1985

Volltextzugriff (PDF)

Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties

Journal of medicinal chemistry, 1991-04, Vol.34 (4), p.1400-1407

1991

Volltextzugriff (PDF)

A new steroidal alkylating agent with improved activity in advanced murine leukemias

Cancer chemotherapy and pharmacology, 1979-01, Vol.3 (1), p.67

1979

Volltextzugriff (PDF)

Confidence Interval about the Response at the Stationary Point of a Response Surface, with an Application to Preclinical Cancer Therapy

Biometrics, 1984-12, Vol.40 (4), p.1125-1130

1984

Volltextzugriff (PDF)

Confidence Regions for Constrained Optima in Response-Surface Experiments

Biometrics, 1983-09, Vol.39 (3), p.759-763

1983

Volltextzugriff (PDF)

Clinical study of hydrazine sulfate in advanced cancer patients

Cancer chemotherapy and pharmacology, 1979-01, Vol.3 (2), p.121

1979

Volltextzugriff (PDF)

Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163)

Cancer chemotherapy and pharmacology, 1980-01, Vol.4 (1), p.49

1980

Volltextzugriff (PDF)

A prospective randomized comparison of protracted infusional 5‐fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid‐atlantic oncology program study

Cancer, 1991-01, Vol.67 (1), p.14-19

1991

Volltextzugriff (PDF)

Survival Analysis of Drug Combinations Using a Hazards Model with Time-Dependent Covariates

Biometrics, 1980-09, Vol.36 (3), p.537-546

1980

Volltextzugriff (PDF)

Review of the application of response surface methodology in the combination therapy of cancer

Cancer treatment reports, 1986-01, Vol.70 (1), p.133

1986

Volltextzugriff (PDF)

Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid

Cancer treatment reports, 1977-01, Vol.61 (1), p.37

1977

Volltextzugriff (PDF)

Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia

Cancer treatment reports, 1987-06, Vol.71 (6), p.581

1987

Volltextzugriff (PDF)

Synthesis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents

Journal of medicinal chemistry, 1975-02, Vol.18 (2), p.195-198

1975

Volltextzugriff (PDF)

Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy

Cancer treatment reports, 1985-07, Vol.69 (7-8), p.867

1985

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Englisch
(202)
Japanisch
(13)
Deutsch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(127)
Life Sciences & Biomedicine
(68)
Humans
(51)
Female
(49)
Oncology
(42)
Technology
(37)
Animals
(34)
Physical Sciences
(33)
Male
(32)
Nuclear Science & Technology
(31)
Mice
(26)
Middle Aged
(25)
Physics
(25)
Biological And Medical Sciences
(24)
Materials Science
(23)
70 Plasma Physics And Fusion Technology
(21)
Antineoplastic Agents
(21)
Exact Sciences And Technology
(20)
Leukemia L1210 - Drug Therapy
(20)
Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study

Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program study

Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancer

A study of infusional cisplatin and infusional fluorouracil for locally advanced or metastatic non-small-cell lung cancer: a Mid-Atlantic Oncology Program study

Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy

Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil

Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples

A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer : a mid-atlantic oncology program study

Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer : a MAOP study

Relationships between various uses of antineoplastic drug-interaction terms

Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium

Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties

A new steroidal alkylating agent with improved activity in advanced murine leukemias

Confidence Interval about the Response at the Stationary Point of a Response Surface, with an Application to Preclinical Cancer Therapy

Confidence Regions for Constrained Optima in Response-Surface Experiments

Clinical study of hydrazine sulfate in advanced cancer patients

Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163)

A prospective randomized comparison of protracted infusional 5‐fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A mid‐atlantic oncology program study

Survival Analysis of Drug Combinations Using a Hazards Model with Time-Dependent Covariates

Review of the application of response surface methodology in the combination therapy of cancer

Antileukemic effect of homo-aza-steroidal ester of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid

Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia

Synthesis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents

Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy

Suchergebnisse filtern